Nitric oxide, skin growth and differentiation: More questions than answers?

Clinical and Experimental Dermatology

Volumn 24, Issue 5, 1999, Pages 388-391

  Weller, R ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CASPASE 3; CYTOKINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN BCL 2; PROTEIN P53;

ANGIOGENESIS; APOPTOSIS; CELL DIFFERENTIATION; CELL GROWTH; HUMAN; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN CARCINOGENESIS; T LYMPHOCYTE; ULTRAVIOLET RADIATION; WOUND HEALING;

APOPTOSIS; HUMANS; NEOPLASMS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PSORIASIS; ULTRAVIOLET RAYS; WOUND HEALING;

EID: 0032833282     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.1999.00509.x     Document Type: Review

References (31)

1. Howlett R. Nobel award stirs up debate on nitric oxide breakthrough. Nature 1998; 395: 625-6.
2. Bruch-Gerharz D, Ruzicka T, Kolb-Bachofen V. Nitric oxide in human skin: current status and future prospects. J Invest Dermatol 1998; 110: 1-7.
3. Weller R. Nitric oxide-a newly discovered chemical transmitter in human skin. Br J Dermatol 1997; 137: 665-72.
4. Kolb H, Kolb-Bachofen V. Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol Today 1998; 19: 556-61.
5. Jackson M, Frame F, Weller R et al. Expression of nitric oxide synthase III (cNOS) mRNA by human skin cells: melanocytes but not keratinocytes express cNOS mRNA. Arch Dermatol Res 1998; 290: 350-2.
6. Wang R, Ghahary A, Shen YJ et al. Human dermal libroblasts produce nitric oxide and express both constitutive and inducible nitric oxide synthase isoforms. J Invest Dermatol 1996; 106: 419-27.
7. Baudouin JE, Tachon P. Constitutive nitric oxide synthase is present in normal human keratinocytes. J Invest Dermatol 1996; 106: 428-31.
8. Kröncke K-D, Fehsel K, Kolb-Bachofeu V. Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 1998; 113: 147-56.
9. Wink DA, Mitchell JB. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Rad Biol Med 1998; 25: 434-56.
10. Cui S, Reichner JS, Mateo RB et al. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res 1994; 54: 2462-7.
11. Adams LB, Franzblau SG, Vavrin Z et al. L-Arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium Ieprae. J Immunol 1991; 147: 1642-6.
12. Xie K, Huang S, Dong Z et al. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 1995; 181: 1333-43.
13. Henseleit U, Rosenbach T, Kolde G. Induction of apoptosis in human HaCaT keratinocytes. Arch Dermatol Res 1996; 288: 676-83.
14. Mannick JB, Asano K, Izumi K et al. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 1994; 79: 1137-46.
15. Dimmeler S, Haendeler J, Nehls M et al. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med 1997; 185: 601-7.
16. Suschek C, Krischel V, Bruch-Gerhartz D et al. Nitric oxide fully protects against UVA-induced apoptosis in tight correlation with Bcl 2 up regulation. J Biol Chem in press.
17. Kuhn A, Fehsel K, Lehmann P et al. Aberrant timing in epidermal expression of Inducible nitric oxide synthase after UV irradiation in cutaneous lupus erythematosus. J Invest Dermatol 1998; 111: 149-53.
18. Deliconstantinos G, Villiotou V, Stravrides JC. Release by ultraviolet B (u.v. B) radiation of nitric oxide (NO) from human keratinocytes: a potential role for nitric oxide in erythema production. Br J Pharmacol 1995; 114: 1257-65.
19. Villiotou V, Deliconstantinos G. Nitric oxide, peroxynitrite and nitroso-compounds formation by ultraviolet A (UVA) irradiated human squamous cell carcinoma: potential role of nitric oxide in cancer prognosis. Anticancer Res 1995; 15: 931-42.
20. Wink DA, Kasprzak KS, Maragos CM et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991; 254: 1001-3.
21. Doi K, Akaike T, Horie H et al. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer 1996; 77: 1598-604.
22. Ambs W, Merriam WG, Ogunfusika MO et al. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cell lines. Nature Med 1998; 4: 1371-6.
23. Bruch-Gerharz D, Fehsel K, Suschek C et al. A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med 1996; 184: 2007-12.
24. Weller R, Dykhuizen R, Leifert C et al. Nitric oxide release accounts for the reduced incidence of cutaneous infections in psoriasis [letter: comment]. J Am Acad Dermatol 1997; 36: 281-2.
25. Wrone-Smith T, Johnson T, Nelson B et al. Discordant expression of Bcl-x and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am J Pathol 1995; 146: 1079-88.
26. Sirsjo A, Karlsson M, Gidlof A et al. Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes. Br J Dermatol 1996; 134: 643-8.
27. Taylor-Robinson AW, Liew FY, Severn A et al. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur J Immunol 1994; 24: 980-4.
28. Krischel V, Bruch Gerharz D, Suschek C et al. Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts. J Invest Dermatol 1998; 111: 286-91.
29. Weller R, Ormerod A. Increased expression of inducible nitric oxide (NO) synthase. Br J Dermatol 1997; 136: 136-7.
30. Yamasaki K, Edington HDJ, McClosky C et al. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J Clin Invest 1998; 101: 967-71.
31. Wang R, Ghahary A, Shen YJ et al. Nitric oxide synthase expression and nitric oxide production are reduced in hypertrophic scar tissue and fibroblasts. J Invest Dermatol 1997; 108: 438-44.